Lauren Liss, Vice President of U.S. Card at Capital One, discusses the company's latest partnership with Hotels.com. The goal of this partnership is to give consumers more flexibility to earn valuable travel rewards.
Liss discusses perks of the partnership that will allow Venture customers to earn 10x miles on hundreds of thousands of hotels, just by paying with their Venture or VentureOne cards on Hotels.com/Venture. The offer works with the Hotels.com® Rewards loyalty program, which allows members to stay 10 nights and get one free. It is also on top of the unlimited miles Venture cardholders earn on all other purchases, which can be redeemed on any airline, flight, rideshare or hotel with zero blackout dates ever.
We also dig into the Capital One Travel Survey and hear about what matters most to millennials when it comes to earning hotel rewards
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
